跳至主要内容
临床试验/NCT02416063
NCT02416063已完成2 期

Caudal Versus Intravenous Dexmedetomidine for Caudal Analgesia in Children: A Randomised Controlled Double Blind Study

University of Jordan0 个研究点目标入组 75 人开始时间: 2014年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
75
主要终点
Time to first analgesic requirement

研究概览

简要总结

The aim of this prospective randomized double-blind study was to compare the analgesic efficacy and the side effects of dexmedetomidine (1 µg.kg-1) co-administered with bupivacaine for caudal analgesia or intravenously in children undergoing infra-umbilical surgery.

详细描述

Dexmedetomidine is used increasingly in pediatric anesthesia practice to prolong the duration of action of caudal block with a local anesthetic agent.But which route of administration of dexmedetomidine is the most beneficial remains unknown.

The investigators performed prospective randomized double-blind study to compare the effects of caudal dexmedetomidine with intravenous dexmedetomidine on postoperative analgesia after caudal bupivacaine in children undergoing infra-umbilical surgery.

75 children (ASAⅠorⅡ,aged 1-6 yr) undergoing infra-umbilical surgery were included in this study. Anesthesia was induced with sevoflurane via a facemask, followed by placement of a laryngeal mask airway. Anesthesia was maintained with sevoflurane 2-3% in oxygen-air.Then,caudal block was applied. Patients were randomly assigned in three groups. Group B-Dcau (n = 25): Caudal bupivacaine 0.25% 1ml/kg plus dexmedetomidine 1µg/kg and 10 ml normal saline i.v.;Group B-Div (n = 25): bupivacaine 0.25% 1ml/kg and dexmedetomidine 1µg/kg(10 ml)i.v.;Group B(n = 25): bupivacaine 0.25% and 10 ml normal saline intravenous

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
1 Year 至 6 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Patients with American Society of Anesthesiologists (ASA) - I
  • Scheduled for lower abdominal and perineal surgery
  • Under general anesthesia

排除标准

  • Hypersensitivity to any local anesthetics
  • Patient has history of allergy, intolerance, or reaction to dexmedetomidine
  • Infections at puncture sites
  • Bleeding diathesis
  • Preexisting neurological disease
  • Children with uncorrected cardiac lesions
  • Children with heart block

研究组 & 干预措施

caudal Dexmedetomidine

Active Comparator

Drug:Caudal Bupivacaine 0.25% 1ml/kg .

Drug:caudal Dexmedetomidine 1μg /kg.

Intravenous :10 ml normal saline

Anesthesia was induced and maintained with sevoflurane

干预措施: Caudal Dexmedetomidine (Drug)

Intravenous Dexmedetomidine

Active Comparator

Drug:Caudal bupivacaine 0.25% 1ml/kg

Drug: Intravenous dexmedetomidine 1µg/kg in a 10 ml volume normal saline

Anesthesia was induced and maintained with sevoflurane

干预措施: Intravenous dexmedetomidine (Drug)

Placebo

Placebo Comparator

Caudal: bupivacaine 0.25% 1ml/kg .

Intravenous: 10 ml Normal saline

Anesthesia was induced and maintained with sevoflurane

干预措施: Placebo (Drug)

结局指标

主要结局

Time to first analgesic requirement

时间窗: 24 hours

Time to first rescue medication. The time from end of surgery to the first requirement of postoperative analgesia,pain score ≥4

次要结局

  • the incidence of emergence agitation(2 hours)
  • Postoperative behaviour scores(2 hours)
  • Blood pressure Perioperative blood pressure readings(2 hours)
  • Side effects(24 hours)
  • Sevoflurane concentration(1 hour)
  • Heart Rate(2 hours)
  • Postoperative pain scores(24 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Khaled Radian Al-zaben

Dr

University of Jordan

相似试验